Drug Research
Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.
Moderna, Inc., biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm, a leading contract development and manufacturing organization (CDMO), announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19...
Drug Research
Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing
Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif. The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used...
Drug Research
Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity
Aurinia Pharmaceuticals Inc. announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp, Switzerland. The dedicated facility (also referred...
Drug Research
Science organisations collaborate to create North East bioscience hub
CPI, FUJIFILM Diosynth Biotechnologies and Teesside University announced a collaboration to accelerate the bioscience sector in the Tees Valley Region. Named the Northern Bio-Accelerator Partnership (NBioP), the new collaboration will create a bioprocessing, biomanufacturing and biopharmaceutical hub in the...
Drug Research
Thermo Fisher Scientific Expands Clinical Supply Chain Services in Europe
To meet accelerating demand for robust clinical supply chain services throughout Europe, Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein, Germany. The new sites will bring much-needed...
Drug Research
Fusion Antibodies and Queens University Belfast Receive Invest Northern Ireland Grant to Boost Research and Development for COVID-19 Antibodies
Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts. Within...
Drug Research
U.S. FDA confirms Pfizer COVID vaccine safe & effective
The FDA 53-page briefing document gives a green signal to Pfizer-BioNTech COVID-19 vaccine. A US roll-out of the vaccine is expected post-approval from an outside panel of scientific advisers who will review the FDA report on Thursday.
As COVID cases...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
